1.
Tran TB, Doan TKC. SOME RISK FACTORS OF CARDIOVASCULAR-METABOLISM AND EVALUATION OF TREATMENT RESULTS WITH EMPAGLIFLOZIN COMBINED METFORMIN IN TYPE 2 DIABETES WITH OVERWEIGHT AND OBESITY. CTJUMP [Internet]. 2026 Aug. 11 [cited 2026 Aug. 27];(33):10-6. Available from: https://tapchi.ctump.edu.vn/index.php/ctump/article/view/1181